Clinical Trial Update: S100B as a Marker of Brain Injury of Preterm Infants

View source ↗

Summary

This document outlines a clinical trial update investigating S100B as a biomarker for brain injury in preterm infants; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Developmental Disabilities
• Periventricular Leukomalacia
• Preterm Birth

Snippet

Sponsor: Sheba Medical Center | Conditions: Premature Birth, Brain Injuries | Status: UNKNOWN